About the journal
BJC Reports is an open-access journal published by Nature Portfolio in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,290 EUR. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Nature Portfolio
- ISSN
- 2731-9377
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,290 EUR
- Articles in DOAJ
- 177
- Declared review time
- 15 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.nature.com/bjcreports/
Index listings
- DOAJ · 2024-05-23
- PUBMED · 2023-06-22
- Indexing
- DOAJ · PUBMED
- APC
- 2,290 EUR
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
177
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
231
Last recorded publication year
2026
h-index
15
i10-index
26
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2024-05-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 41%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918752188106676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- BRCA gene mutations in cancer
- BRCA gene mutations in cancer
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Global Cancer Incidence and Screening
- Genetic factors in colorectal cancer
Show all subjects (50)
- Genetic factors in colorectal cancer
- Global Cancer Incidence and Screening
- Lung Cancer Treatments and Mutations
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Lung Cancer Treatments and Mutations
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Glioma Diagnosis and Treatment
- Immune cells in cancer
- Lung Cancer Diagnosis and Treatment
- Cancer survivorship and care
- Cancer survivorship and care
- Glioma Diagnosis and Treatment
- Melanoma and MAPK Pathways
- Cancer Risks and Factors
- Lung Cancer Diagnosis and Treatment
- Cancer Risks and Factors
- Immune cells in cancer
- Cancer Cells and Metastasis
- Advanced Breast Cancer Therapies
- Pancreatic and Hepatic Oncology Research
- Immunotherapy and Immune Responses
- Cancer, Hypoxia, and Metabolism
- AI in cancer detection
- Immunotherapy and Immune Responses
- Head and Neck Cancer Studies
- Pancreatic and Hepatic Oncology Research
- Endometrial and Cervical Cancer Treatments
- AI in cancer detection
- Advanced Breast Cancer Therapies
- Head and Neck Cancer Studies
- Endometrial and Cervical Cancer Treatments
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Melanoma and MAPK Pathways
- Cancer, Hypoxia, and Metabolism
- Renal cell carcinoma treatment
- Ovarian cancer diagnosis and treatment
- Renal cell carcinoma treatment
Keywords (DOAJ)
- clinical studies
- translational therapeutics
- molecular diagnostics
- genetics and genomics
- cellular and molecular biology
- epidemiology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ